Position in CHRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,581,256
+$36,936 QoQ
Shares Held
1,129,470
+23.6% QoQ
Ownership
0.731%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. CHRS ranks #245 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,581,256 | 1,129,470 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,544,320 | 913,800 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,126,503 | 793,313 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,394,685 | 850,418 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $654,761 | 895,708 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $764,327 | 947,124 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,388,975 | 1,006,505 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $932,603 | 896,735 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,580,779 | 913,746 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,202,721 | 921,641 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,216,838 | 966,018 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,599,169 | 962,345 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,399,930 | 796,237 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,223,487 | 763,668 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,948,076 | 751,020 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,275,959 | 757,124 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,407,149 | 746,844 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,104,130 | 705,200 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,668,385 | 731,102 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $11,911,627 | 741,234 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,516,454 | 760,409 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,530,520 | 720,775 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $13,136,201 | 755,823 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $14,190,499 | 773,746 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,454,186 | 809,305 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $12,661,232 | 780,594 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||